IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.
about
From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel BiomarkersDetection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencingEvaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancersUse of targeted exome sequencing in genetic diagnosis of Chinese familial hypercholesterolemiaAn ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia.The promise and challenge of high-throughput sequencing of the antibody repertoire.Limited detection of IgH gene rearrangements in plasma of patients with primary central nervous system lymphomaInfluence of seasonal exposure to grass pollen on local and peripheral blood IgE repertoires in patients with allergic rhinitisTargeted exome sequencing identified novel USH2A mutations in Usher syndrome families.Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric CancerComprehensive molecular diagnosis of Bardet-Biedl syndrome by high-throughput targeted exome sequencing.Biomarkers in NHL.Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.Wide mutation spectrum and frequent variant Ala27Thr of FBN1 identified in a large cohort of Chinese patients with sporadic TAAD.Systematic Comparative Evaluation of Methods for Investigating the TCRβ Repertoire.Circulating tumor-derived mutant mitochondrial DNA: a predictive biomarker of clinical prognosis in human squamous cell carcinoma.Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia.Advances in the medical research and clinical applications on the plasma DNANucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer.Use of high-throughput targeted exome sequencing in genetic diagnosis of Chinese family with congenital cataract.Targeted next-generation sequencing reveals multiple deleterious variants in OPLL-associated genesA novel deleterious mutation in the COMP gene that causes pseudoachondroplasiaAberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphomaCirculating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia.The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies.The role of next-generation sequencing in understanding the genomic basis of diffuse large B cell lymphoma and advancing targeted therapies.Cell-free DNA - Minimally invasive marker of hematological malignancies.Genetic background and evolution of relapses in aggressive B-cell lymphomas.Detecting and monitoring lymphoma with high-throughput sequencing.Immunoglobulin rearrangement analysis from multiple lesions in the same patient using next-generation sequencing.Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis.Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignanciesSporadic Hirschsprung Disease: Mutational Spectrum and Novel Candidate Genes Revealed by Next-generation Sequencing.High frequency of identical clonal immunoglobulin DNA in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphoma: prospective multicenter trial of the AIDS malignancies consortium (AMC 064).Genetic analysis of sick sinus syndrome in a family harboring compound CACNA1C and TTN mutations.Evaluation diagnostic usefulness of immunoglobulin light chains (Igκ, Igλ) and incomplete IGH D-J clonal gene rearrangements in patients with B-cell non-Hodgkin lymphomas using BIOMED-2 protocol.
P2860
Q28078702-614CC058-E079-423D-A7EA-2E9745CD8115Q28280303-761C5760-6C7D-4CB4-A8EC-97FB782A3E87Q28282973-C4933DBA-FC2B-420D-B0A5-AC68B7EC0A42Q28537747-5C84446E-3F39-4FD1-984F-1AA2854EFB1AQ33590850-738FDA7A-75AC-4D15-B1CD-7A7A0AFA7B3AQ33614375-9A37977F-4336-4D5E-B87E-DD1EE7CCF2B4Q33962293-069EE4C4-2BC8-44D6-81B9-58F701DB32CFQ34048994-9C6ABA32-84AC-4634-AE00-19DD111BAB87Q34121184-403D88B7-DB96-4515-BCEA-0864B87FAFD2Q34758486-84C82786-BDE5-42BE-87E4-3FA56F0E3BF7Q34796660-7344F581-F309-4FF9-B6D9-27A37579A7E2Q35114773-9F52A6F1-FC45-4B27-9677-A8A6848C7649Q35679365-D27DFD4E-A85E-4125-8169-DBF5C8B53402Q35723986-F23D9109-0322-466C-A6BD-362CD160B671Q35953455-E33091B6-45A4-4F75-8C50-A2E90DA428FAQ35971628-2E6CAD82-60A6-4906-B859-914EDA5264E7Q36236470-A7090CC3-D102-4932-B1AE-062D190B8A9AQ36425440-972F5B1B-98D9-44F2-B1B6-695B1D42EE46Q36508665-BF36C81D-C8DE-455D-AD07-982E41D68E96Q36888450-A28E6C20-47D2-4EA8-AF2E-37E2A9A0FF52Q36951189-F04A236C-308B-480C-AEE2-690DC3C58433Q36953679-8BD667E1-5F90-4DDA-B065-B883F2A4830AQ36985579-8D5025BC-9AF9-4D2A-A0F6-2B97074BF330Q37240290-94D704FC-B197-4458-9230-C561AC4D1268Q37710733-36B68A2B-804A-4744-AB3B-9F3097612F33Q38201053-B59C00BA-5E73-4595-BA84-533C5D4ACEB3Q38664822-72254051-4788-4163-9A39-D51ED76F9654Q38686561-5F1C97FE-681C-4154-B8DD-4C7CD7B95313Q39336821-7B48F018-2D4D-4634-97FD-612BFCBB71B3Q40048412-92E8060E-1823-44A7-8202-CC68E618BB60Q42147130-6C916569-4D17-4B18-9A20-467AE7987DB5Q42384499-6E138E53-946E-40D1-9AB3-B141BBA4C7A0Q42421291-A552A48C-D13C-4257-80C2-C52D0DD548C8Q45942857-02CC5585-8FA4-4F11-8CF7-90E7FC54D725Q48649466-729190BF-9782-44EC-9DCC-1B92EA122EE5Q52345230-80EE9B1E-1DA2-410F-9972-491D71CEE2AAQ54206951-78488E60-1B2D-45C2-84A7-9A42A8052738
P2860
IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.
@ast
IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.
@en
type
label
IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.
@ast
IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.
@en
prefLabel
IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.
@ast
IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.
@en
P2093
P2860
P356
P1433
P1476
IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.
@en
P2093
Luis A Diaz
Nickolas Papadopoulos
Nina Wagner-Johnston
Richard F Ambinder
Yuchen Jiao
P2860
P304
P356
10.18632/ONCOTARGET.235
P407
P577
2011-03-01T00:00:00Z